CVKD
Price
$14.45
Change
-$1.05 (-6.77%)
Updated
May 9 closing price
Capitalization
28.03M
88 days until earnings call
VYGR
Price
$3.17
Change
-$0.26 (-7.58%)
Updated
May 9 closing price
Capitalization
175.42M
81 days until earnings call
Ad is loading...

CVKD vs VYGR

Header iconCVKD vs VYGR Comparison
Open Charts CVKD vs VYGRBanner chart's image
Cadrenal Therapeutics
Price$14.45
Change-$1.05 (-6.77%)
Volume$38.43K
Capitalization28.03M
Voyager Therapeutics
Price$3.17
Change-$0.26 (-7.58%)
Volume$756.12K
Capitalization175.42M
CVKD vs VYGR Comparison Chart
Loading...
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVKD vs. VYGR commentary
May 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVKD is a Buy and VYGR is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 12, 2025
Stock price -- (CVKD: $14.45 vs. VYGR: $3.17)
Brand notoriety: CVKD and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVKD: 146% vs. VYGR: 211%
Market capitalization -- CVKD: $28.03M vs. VYGR: $175.42M
CVKD [@Biotechnology] is valued at $28.03M. VYGR’s [@Biotechnology] market capitalization is $175.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVKD’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • CVKD’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than CVKD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVKD’s TA Score shows that 4 TA indicator(s) are bullish while VYGR’s TA Score has 6 bullish TA indicator(s).

  • CVKD’s TA Score: 4 bullish, 4 bearish.
  • VYGR’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than CVKD.

Price Growth

CVKD (@Biotechnology) experienced а -12.16% price change this week, while VYGR (@Biotechnology) price change was -12.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

CVKD is expected to report earnings on Aug 07, 2025.

VYGR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($175M) has a higher market cap than CVKD($28M). CVKD YTD gains are higher at: -0.276 vs. VYGR (-44.092). CVKD has higher annual earnings (EBITDA): -7.61M vs. VYGR (-97.25M). VYGR has more cash in the bank: 236M vs. CVKD (10M). CVKD has less debt than VYGR: CVKD (0) vs VYGR (42M). VYGR has higher revenues than CVKD: VYGR (67M) vs CVKD (0).
CVKDVYGRCVKD / VYGR
Capitalization28M175M16%
EBITDA-7.61M-97.25M8%
Gain YTD-0.276-44.0921%
P/E RatioN/A6.00-
Revenue067M-
Total Cash10M236M4%
Total Debt042M-
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
38
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
8
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CVKDVYGR
RSI
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
80%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 18 days ago
87%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VVOIX20.660.03
+0.15%
Invesco Value Opportunities Y
NELAX56.30-0.01
-0.02%
Nuveen Equity Long/Short A
MNHIX25.08-0.01
-0.04%
Manning & Napier Pro-Blend Max Term I
PETZX14.02-0.02
-0.14%
Gabelli Pet Parents'™
HIMDX21.57-0.05
-0.23%
Hennessy Cornerstone Mid Cap 30 Instl

CVKD and

Correlation & Price change

A.I.dvisor tells us that CVKD and MNPR have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVKD and MNPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVKD
1D Price
Change %
CVKD100%
-6.77%
MNPR - CVKD
30%
Poorly correlated
-6.96%
GDTC - CVKD
29%
Poorly correlated
-3.47%
LQDA - CVKD
25%
Poorly correlated
-0.59%
WHWK - CVKD
23%
Poorly correlated
+3.66%
VYGR - CVKD
22%
Poorly correlated
-7.58%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-7.58%
RGNX - VYGR
49%
Loosely correlated
+5.17%
TRDA - VYGR
48%
Loosely correlated
-2.78%
XENE - VYGR
47%
Loosely correlated
-1.46%
IMNM - VYGR
47%
Loosely correlated
-3.24%
RCKT - VYGR
47%
Loosely correlated
-0.71%
More